Predictive value of serum bradykinin and desArg<sup>9</sup>-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series.

导出 OA

翻译打印收藏纠错

第一作者： Xu,Qian

第一单位： Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA; Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, 325035, PR China.

作者： Xu,Qian ^[1] ; Duc T M,Nguyen ^[2] ; Yaojun,Li ^[3] ; Jianxin,Lyu ^[4] ; Edward A,Graviss ^[5] ; Tony Y,Hu ^[6]

作者单位： Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA; Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, 325035, PR China. ^[1] HMRI Molecular Tuberculosis Laboratory, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. ^[2] Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. ^[3] Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, 325035, PR China. ^[4] HMRI Molecular Tuberculosis Laboratory, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. Electronic address: eagraviss@houstonmethodist.org. ^[5] Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA; Weill Cornell Medical College of Cornel University, New York City, NY, 10065, USA. Electronic address: yhu@houstonmethodist.org. ^[6]

关键词 Antibiotics Bradykinin Outcome Recurrence Treatment response Tuberculosis